Recorded June 15, 2016 | On-Demand Webinar
On May 5, FDA issued the final “deeming rule,” a lengthy set of regulations detailing FDA’s authority to regulate electronic nicotine delivery systems (ENDS), cigars, pipe tobacco, and a number of other products. This two-part webinar will offer a brief but thorough look at the recently promulgated Deeming Regulations, including FDA, industry, and public health perspectives. In the first part, FDA’s Director for the Center for Tobacco Products (CTP), Mitch Zeller, will offer his perspective on the policy behind Deeming, the critical changes it would have on industry, and the impact it is likely to have on public health. In the second part, an expert panel of lawyers and compliance experts will explore the ways in which affected companies can evolve and adapt to the new regulatory environment and consider the impact on public health.
Mitch Zeller, Director for the Center for Tobacco Products (CTP), FDA
Stacy Ehrlich, Partner, Kleinfeld, Kaplan & Becker, LLP, and Member, FDLI Board of Directors
Joe G. Gitchell, President, Pinney Associates
Ellen Vargyas, General Counsel and Corporate Secretary, Truth Initiative